Kimura H, Onozawa M, Hashiguchi J, Hidaka D, Kanaya M, Matsukawa T, Okada H, Kondo T, Matsuno Y, Teshima T. Hereditary thrombocythemia due to splicing donor site mutation of THPO in a Japanese family Ann Hematol. 2024 Jan;103(1):89-96. doi: 10.1007/s00277-023-05523-9. Epub 2023 Nov 14. PMID: 37962621
Ichikawa T, Tamura T, Takahata M, Ishio T, Ibata M, Kasahara I, Minauchi K, Yamamoto S, Teshima T, Fukuhara T. Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study. Br J Haematol. 2024 Mar;204(3):815-820. doi: 10.1111/bjh.19143. Epub 2023 Oct 5. PMID: 37795527
Sugita J, Kuroha T, Ishikawa J, Eto T, Fukushima K, Yokota I, Akashi K, Taniguchi S, Harada M, Teshima T. Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor. Bone Marrow Transplant. 2024 Mar;59(3):344-349. doi: 10.1038/s41409-023-02162-6. Epub 2023 Dec 19. PMID: 38114645
Goto H, Sugita J, Hasegawa Y, Hayasaka K, Sunagoya K, Hatase R, Nishida M, Ichihashi Y, Odera M, Senjo H, Yokoyama S, Ara T, Shiratori S, Endo T, Hino M, Maeda Y, Sawa M, Sato N, Teshima T. Efficacy and Safety of Single-dose Pegfilgrastim for CD34 + Cell Mobilization in Healthy Volunteers: A Phase 2 Study. Transplantation. 2024 Apr 1;108(4):996-1003. doi: 10.1097/TP.0000000000004880. Epub 2024 Mar 23. PMID: 38012835
Chiba M, Shimono J, Suto K, Ishio T, Endo T, Goto H, Hasegawa H, Maeda M, Teshima T, Yang Y, Nakagawa M. Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma. Blood. 2024 Apr 4;143(14):1379-1390. doi: 10.1182/blood.2023021423. PMID: 38142436
Hayase E, Ara T, Saito Y, Takahashi S, Yoshioka K, Ohigashi H, Ogasawara R, Yokoyama E, Yamakawa T, Ebata K, Hasegawa Y, Tomizuka K, Teshima T. R-Spondin1 protects gastric stem cells and mitigates gastric GVHD in allogeneic hematopoietic stem cell transplantation. Blood Adv. 2024 Feb 13;8(3):725-731. doi: 10.1182/bloodadvances.2023011034. PMID: 38147622
Dreyling M, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, María Ferreri AJ, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Paule I, Zia A, Awasthi R, Han X, Germano D, O'Donovan D, Ramos R, Maier HJ, Masood A, Thieblemont C, Schuster SJ. Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood. 2024 Apr 25;143(17):1713-1725. doi: 10.1182/blood.2023021567. PMID: 38194692
Miyashita N, Onozawa M, Matsukawa T, Mori A, Hidaka D, Minauchi K, Shigematsu A, Hashiguchi J, Igarashi T, Kakinoki Y, Tsutsumi Y, Ibata M, Wakasa K, Fujimoto K, Ishihara T, Sakai H, Iyama S, Oyake T, Kondo T, Teshima T. Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax-based therapy in the real world: Hokkaido Leukemia Net Study. Br J Haematol. 2024 Apr;204(4):1549-1553. doi: 10.1111/bjh.19292. Epub 2024 Jan 18. PMID: 38238885
Ramirez P, Atsuta Y, Alseraihy A, Okamoto S, Teshima T, Aljurf M, Majhail NS, Rondelli D, Chao N, Flowers ME. American Society for Transplantation and Cellular Therapy International Affairs Committee: Report of the 4th Workshop on Quality as a Development Tool for Hematopoietic Cell Transplantation Programs at the 2023 Tandem BMT Meetings. Transplant Cell Ther. 2024 May;30(5):468-474. doi: 10.1016/j.jtct.2024.02.011. Epub 2024 Feb 10. PMID: 38346644
Kimura H, Onozawa M, Matsukawa T, Goto H, Kondo T, Teshima T. Relative impact of THPO mutation causing hereditary thrombocythemia. Exp Hematol. 2024 Jun;134:104208. doi: 10.1016/j.exphem.2024.104208. Epub 2024 Mar 26. PMID: 38548144
Nakano K, Seimiya M, Yamazaki K, Yasuda K, Yamashita N, Goto H, Teshima T. Patent blue interferes with the measurement of lipemia index in a patient with sentinel lymph node. Lab Med. 2024 Sep 4;55(5):672-675. doi: 10.1093/labmed/lmae028. PMID: 38619047
Teshima T, Onishi Y, Kato K, Taniguchi S, Miyamura K, Fukushima K, Kato J, Ishikawa T, Doki N, Nakamae H, Maeda Y, Inamoto Y, Okada M, Maki A, Shimada F, Tajima T, Wroclawska M, Zeiser R, Onizuka M. Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial. Int J Hematol. 2024 Jul;120(1):106-116. doi: 10.1007/s12185-024-03772-6. Epub 2024 May 25. PMID: 38796666
Chen YB, Mohty M, Zeiser R, Teshima T, Jamy O, Maertens J, Purtill D, Chen J, Cao H, Rossiter G, Jansson J, Fløisand Y. Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Nat Med. 2024 Aug;30(8):2277-2287. doi: 10.1038/s41591-024-03016-4. Epub 2024 Jun 6. PMID: 38844797
Izumiyama K, Inao T, Goto H, Harada S, Senjo H, Suto K, Hashiguchi J, Ogasawara R, Saga T, Igarashi T, Wakasa K, Kasahara I, Takeda Y, Yamaguchi K, Shigematsu A, Takahata M, Fujimoto K, Haseyama Y, Nagashima T, Sakai H, Kakinoki Y, Kurosawa M, Yokota I, Teshima T. Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group. Haematologica. 2024 Nov 1;109(11):3631-3640. doi: 10.3324/haematol.2023.284841. PMID: 38867578
Yamamoto H, Tamura T, Ichikawa T, Taguchi Y, Mori K, Oguri S, Suzuki R, Suzuki S, Teshima T, Fukuhara T. Generation of recombinant viruses directly from clinical specimens of COVID-19 patients. J Clin Microbiol. 2024 Jul 16;62(7):e0004224. doi: 10.1128/jcm.00042-24. Epub 2024 Jun 14. PMID: 38874339
Hasegawa Y, Hashimoto D, Zhang Z, Miyajima T, Saito Y, Li W, Kikuchi R, Senjo H, Sekiguchi T, Tateno T, Chen X, Yokoyama E, Takahashi S, Ohigashi H, Ara T, Hayase E, Yokota I, Teshima T. GVHD targets organoid-forming bile duct stem cells in a TGF-β-dependent manner. Blood. 2024 Aug 22;144(8):904-913. doi: 10.1182/blood.2023023060. PMID: 38905638
Inamoto Y, Kato K, Kawakita T, Onishi Y, Matsuoka KI, Shiratori S, Ikegame K, Hiramoto N, Toyosaki M, Katayama Y, Murayama S, Sasagawa Y, Maeda Y, Hatake K, Teshima T. An open-label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid-dependent/steroid-resistant chronic GVHD. Am J Hematol. 2024 Oct;99(10):1917-1926. doi: 10.1002/ajh.27424. Epub 2024 Jun 27. PMID: 38934629
Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Takahashi N, Kim I, Etienne G, Andorsky D, Issa GC, Larson RA, Bombaci F, Kapoor S, McCulloch T, Malek K, Yau L, Ifrah S, Hoch M, Cortes JE, Hughes TP; ASC4FIRST Investigators. Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. N Engl J Med. 2024 Sep 12;391(10):885-898. doi: 10.1056/NEJMoa2400858. Epub 2024 May 31. PMID: 38820078
Takizawa J, Teshima T, Ennishi D, Ichikawa S, Suzuki R, Kojima A, Takahashi Y, Hayashi N, Kawasumi H, Murayama K, Cheung P, Kawata T, Izutsu K. Safety and efficacy of acalabrutinib and obinutuzumab in treatment-naive chronic lymphocytic leukemia: a Japanese phase 1 study. Leuk Lymphoma. 2024 Nov;65(11):1586-1594. doi: 10.1080/10428194.2024.2370436. Epub 2024 Jul 1. PMID: 38952054
Kanda J, Mitsuyoshi T, Sakurai M, Nishimori H, Murata M, Uchida N, Doki N, Inamoto Y, Nishida T, Tanaka M, Katayama Y, Eto T, Matsuoka KI, Yoshihara S, Sawa M, Kawakita T, Jun G, Kurata M, Ichinohe T, Fukuda T, Teshima T, Atsuta Y, Terakura S. Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program Registry. Transplant Cell Ther. 2024 Sep;30(9):907.e1-907.e16. doi: 10.1016/j.jtct.2024.06.023. Epub 2024 Jul 2. PMID: 38960321
Kongtim P, Vittayawacharin P, Zou J, Srour S, Shaffer B, Shapiro RM, Varma A, McGuirk J, Dholaria BR, McCurdy SR, DeZern AE, Bejanyan N, Bashey A, Furst S, Castagna L, Mariotti J, Ruggeri A, Bailen R, Teshima T, Xiao-Jun H, Bonfim C, Aung F, Cao K, Carpenter PA, Hamadani M, Askar M, Fernandez-Vina M, Girnita A, Ciurea SO. ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti- HLA Antibodies. Transplant Cell Ther. 2024 Dec;30(12):1139-1154. doi: 10.1016/j.jtct.2024.09.005. Epub 2024 Sep 10. PMID: 39260570
Shiratori S, Fukushima K, Onishi Y, Doki N, Goto T, Okada M, Nakamae H, Maeda Y, Kato K, Ishikawa T, Kondo T, Toyosaki M, Ikeda T, Uchida N, Maki A, Shimada F, Tajima T, Stefanelli T, Teshima T. Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study. Int J Hematol. 2024 Dec;120(6):705-716. doi: 10.1007/s12185-024-03850-9. Epub 2024 Oct 3. PMID: 39361234
Senjo H, Hashimoto D, Teshima T. Calcineurin inhibitor blocks tolerance by suppressing donor T cell terminal exhaustion after allogeneic hematopoietic cell transplantation. J Clin Invest. 2024 Oct 15;134(20):e184332. doi: 10.1172/JCI184332. PMID: 39403931
Suto K, Takei N, Yokoyama K, Chiba M, Ishio T, Maeda M, Goto H, Endo T, Teshima T, Yang Y, Nakagawa M. Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma. Leukemia. 2025 Jan;39(1):243-247. doi: 10.1038/s41375-024-02441-1. Epub 2024 Oct 21. PMID: 39433928
Nishino H, Murayama M, Iwano H, Kagiyama N, Nakamura Y, Akama Y, Toki M, Takamatsu S, Okada T, Chiba Y, Nakabachi M, Yokoyama S, Goto M, Suzuki Y, Ishizaka S, Motoi K, Tamaki Y, Aoyagi H, Nakamura K, Kaga S, Watanabe C, Kamiya K, Nagai T, Teshima T, Anzai T. Validation of Left Ventricular Filling Pressure Evaluation by Order of Tricuspid and Mitral Valve Opening in Patients With Atrial Fibrillation. Circ Cardiovasc Imaging. 2024 Nov;17(11):e017134. doi: 10.1161/CIRCIMAGING.124.017134. Epub 2024 Nov 13. PMID: 39534982
Matsukawa T, Onozawa M, Kondo T, Kanaya M, Hidaka D, Ota S, Mori A, Shigematsu A, Miyagishima T, Kakinoki Y, Hashiguchi J, Yamamoto S, Yamamoto M, Wakasa K, Takahata M, Ishihara T, Haseyama Y, Fujimi A, Igarashi T, Sarashina T, Iyama S, Kobayashi R, Sakai H, Fujimoto K, Inamura J, Kanisawa Y, Hirabayashi S, Endo T, Hashimoto D, Teshima T. FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD- positive AML. Ann Hematol. 2024 Dec;103(12):5333-5340. doi: 10.1007/s00277-024-06125-9. Epub 2024 Nov 30. PMID: 39614924
Goto H, Kumode T, Mishima Y, Kataoka K, Ogawa Y, Kanemura N, Shimada K, Uchida T, Kuroe Y, Kawasaki A, Sato J, Teshima T. Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1. Int J Clin Oncol. 2024 Dec 9. doi: 10.1007/s10147-024-02662-5. Online ahead of print. PMID: 39652156
Toyosaki M, Machida S, Tomizawa D, Okada M, Sawa M, Ueda Y, Omi A, Koroki Y, Teshima T. Temporal changes in corticosteroid dose during ibrutinib treatment in patients with cGVHD and pulmonary involvement. Int J Hematol. 2024 Dec 10. doi: 10.1007/s12185-024-03882-1. Online ahead of print. PMID: 39653871
Takenaka K, Fuji S, Matsukawa T, Uchida N, Kobayashi T, Tanaka M, Ara T, Ikegame K, Ozawa Y, Kanda Y, Sawa M, Maruyama Y, Fukuda T, Nakamae H, Kimura T, Ogata M, Seo S, Atsuta Y, Matsuo K, Nakasone H. Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection. Ann Hematol. 2024 Jan;103(1):285-296. doi: 10.1007/s00277-023-05474-1. Epub 2023 Nov 10. PMID: 37947825
Kurita N, Imahashi N, Chiba S, Tanaka M, Kobayashi H, Uchida N, Kuriyama T, Anzai N, Nawa Y, Nakano N, Ara T, Onizuka M, Katsuoka Y, Koi S, Kimura T, Ichinohe T, Atsuta Y, Kanda J; Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Comparison of fludarabine-based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry-based study. Am J Hematol. 2024 Feb;99(2):236-244. doi: 10.1002/ajh.27172. Epub 2024 Jan 2. PMID: 38165068
Fukunaga K, Ikegame K, Nakamae H, Doki N, Fukuda T, Kondo Y, Ara T, Eto T, Mori Y, Matsuoka KI, Kanda Y, Onizuka M, Atsuta Y, Ichinohe T, Morishima S, Kanda J; JSTCT HLA Working Group. HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA heterozygous donors: a retrospective nationwide analysis. Int J Hematol. 2024 Feb;119(2):173-182. doi: 10.1007/s12185-023-03693-w. Epub 2024 Jan 17. PMID: 38233701
Kim H, Mizuno K, Masuda K, Sakurai M, Ara T, Naito K, Uehara Y, Yamamoto G, Osada M, Machida S, Horio T, Fukushima K, Mori Y, Ichinohe T, Fukuda T, Atsuta Y, Kataoka K. A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis Transplant Cell Ther. 2024 Apr;30(4):419.e1-419.e12. doi: 10.1016/j.jtct.2024.01.071. Epub 2024 Jan 22. PMID: 38266963
Goto H, Ito S, Kizaki M, Yamaguchi M, Fukuhara N, Kato K, Saito T, Terui Y, Okubo S, Soshin T, Zeng J, Honda H, Badawi M, Ross JA, Izutsu K. Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma. Int J Clin Oncol. 2024 Feb;29(2):232-240. doi: 10.1007/s10147-023-02443-6. Epub 2023 Dec 29. PMID: 38157190
Ichikawa T, Hiono T, Okamatsu M, Maruyama J, Kobayashi D, Matsuno K, Kida H, Sakoda Y. Hemagglutinin and neuraminidase of a non-pathogenic H7N7 avian influenza virus coevolved during the acquisition of intranasal pathogenicity in chickens Arch Virol. 2024 Sep 22;169(10):207. doi: 10.1007/s00705-024-06118-z. PMID: 39307848
Goudarzi H, Onozawa M, Takahashi M. Impact of the Covid-19 pandemic and ensuing online teaching on pre-clinical medical education. BMC Med Educ. 2024 Jan 17;24(1):66. doi: 10.1186/s12909-023-04967-x. PMID: 38233801
Onozawa M, Kusumoto S, Najima Y, Hashimoto H, Okada K, Tamaki M, Tanaka M, Sato T, Takahashi T, Hatano K, Onodera K, Moriuchi Y, Yakushijin K, Kanda J, Nagafuji K, Ogata M, Nakano N, Tamori A, Mizokami M. Outcomes of Cessation of Nucleost)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoletic Stem Cell Iransplantation: A Nationwide Retrospective Study. Transplant Cell Ther. 2024 Mar;30(3):330.e1-330.e8. doi: 10.1016/j.jtct.2024.01.059. Epub 2024 Jan 17. PMID: 38242442
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3. J Clin Oncol. 2024 May 20;42(15):1766-1775. doi: 10.1200/JCO.23.02474. Epub 2024 Mar 12. PMID: 38471061
Usuki K, Miyamoto T, Yamauchi T, Ando K, Ogawa Y, Onozawa M, Yamauchi T, Kiyoi H, Yokota A, Ikezoe Katsuoka Y, Takada S, Aotsuka N, Morita Y, Ishikawa T, Asada N, Ota S, Dohi A, Morimoto K, Imai S, Kishimoto U, Akashi K, Miyazaki Y; Study Group for NS-87/CPX-351. A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia. Int J Hematol. 2024 Jun;119(6):647-659. doi: 10.1007/s12185-024-03733-z. Epub 2024 Mar 26. PMID: 38532078
Minakata D, Uchida T, Nakano A, Takase K, Tsukada N, Kosugi H, Kawata E, Nakane T, Takahashi H, Endo T, Nishiwaki S, Fujiwara H, Saito AM, Saito TI, Akashi K, Matsumura I, Mitani K. Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: cross-sectional study. Int J Hematol. 2024 Feb;119(2):183-195. doi: 10.1007/s12185-023-03685-w. Epub 2024 Jan 3. PMID: 38172385
Kimura K, Tanuma J, Kimura M, Imamura J, Yanase M, Ieiri I, Kurosaki M, Watanabe T, Endo T, Yotsuyanagi H, Gatanaga H. Safety and tolerability of OP-724 in patients with haemophilia and liver cirrhosis due to HIV/HCV coinfection: an investigator-initiated, open-label, non-randomised, single-centre, phase I study. BMJ Open Gastroenterol. 2024 Apr 27;11(1):e001341. doi: 10.1136/bmjgast-2023-001341. PMID: 38677720
Koga M, Fukuda A, Nojima M, Ishizaka A, Itoh T, Eguchi S, Endo T, Kakinuma A, Kinai E, Goto T, Takahashi S, Takeda H, Tanaka T, Teruya K, Hanai J, Fujii T, Fujitani J, Hosaka T, Mita E, Minami R, Moro H, Yokomaku Y, Watanabe D, Watanabe T, Yotsuyanagi H. Non-acquired immunodeficiency syndrome defining malignancies in people living with haemophilia and human immunodeficiency virus after direct-acting antiviral era. Glob Health Med. 2024 Oct 31;6(5):316-323. doi: 10.35772/ghm.2024.01036. PMID: 39483444
Kawabori M, Shichinohe H, Kahata K, Miura A, Maeda K, Ito YM, Mukaino M, Kogawa R, Nakamura K, Gotoh S, Kurisu K, Fujimura M. Phase I/II trial of intracerebral transplantation of autologous bone marrow stem cells combined with recombinant peptide scaffold for patients with chronic intracerebral haemorrhage: a study protocol. BMJ Open. 2024 Dec 2;14(12):e083959. doi: 10.1136/bmjopen-2024-083959. PMID: 39622566
Kawabori M, Kuroda S, Shichinohe H, Kahata K, Shiratori S, Ikeda S, Harada T, Hirata K, Tha KK, Aragaki M, Terasaka S, Ito YM, Nishimoto N, Ohnishi S, Yabe I, Kudo K, Houkin K, Fujimura M. Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke. Med. 2024 May 10;5(5):432-444.e4. doi: 10.1016/j.medj.2024.02.009. Epub 2024 Mar 27. PMID: 38547868
Oguri S, Iwasaki S, Inao T, Yokota I, Murakami K, Tanaka K, Hayasaka K, Fujisawa S, Watanabe C, Konno S, Murakami M, Teshima T Evaluation of the Loopamp SARS-CoV-2 detection kit using saliva for the detection of SARS-CoV-2 Omicron. Laboratory Medicine International(LMI). 2024 3(3) . doi: 10.51041/lmi.3.3_70.
Hagiwara T, Yotsuyanagi H, Fujii T, Endo T, Nagao A, Mita E, Yotsumoto M, Amano K, Ito T, Tokomatsu Y, Ukita M, Suzuki T, Watanabe T, Kinai E, Fukutake K. Pan-Genotypic DAA Therapy for HCV Genotypes Not Covered by Health Insurance for Hemophilia Patients with or without HIV in Japan: Report of a Joint Multi Institutional Study of the Clinical Study Group for AIDS Drugs. The Journal of AIDS Research. 26: 7-13, 2024.
英文総説
Goto H, Onozawa M, Teshima T. Novel CAR T cell therapies for patients with large B cell lymphoma. Int J Hematol. 2024 Jul;120(1):6-14. doi: 10.1007/s12185-024-03792-2. Epub 2024 May 25. PMID: 38795249
英文症例報告
Kikuchi R, Onozawa M, Nagai J, Okada S, Hasegawa Y, Ohigashi H, Mitamura S, Maeda T, Takakuwa E, Fujieda Y, Goto H, Hashimoto D, Matsuno Y, Teshima T. Type 1 Cryoglobulinemic Vasculitis Due to Monoclonal Gammopathy of Undetermined Significance Successfully Treated by Bortezomib Plus Dexamethasone. Intern Med. 2024 Feb 15;63(4):541-545. doi: 10.2169/internalmedicine.2053-23. Epub 2023 Jun 14. PMID: 37316269
Kosaka N, Uchiyama T, Onozawa M, Nagai J, Koya J, Ishizaka S, Nagai T, Ikebe Y, Kato K, Tanei ZI, Sakakibara-Konishi J, Hasegawa Y, Ohigashi H, Goto H, Hashimoto D, Ujiie H, Hirano S, Konno S, Anzai T, Taniguchi K, Tanaka S, Teshima T. Acute Onset of Constrictive Pericarditis Due to Acute Myelomonocytic Leukemia: A Case and Literature Review. Intern Med. 2024 Dec 15;63(24):3359-3365. doi: 10.2169/internalmedicine.3505-24. Epub 2024 Apr 16. PMID: 38631853
Haga Y, Ohara A, Yakuwa T, Yamashita A, Udo M, Matsuoka M, Ohara H, Yasumoto A, Takahashi H. Persistently High Platelet Factor 4 Levels in an Adolescent with Recurrent Late Thrombotic Complications after SARS-CoV-2 mRNA Vaccination. Hematol Rep. 2024 Jul 29;16(3):504-511. doi: 10.3390/hematolrep16030048. PMID: 39189244
Miyamori M, Ichikawa T, Inamura N, Takekawa H, Sakoda K, Yamada K, Suzuki F. Primary lymphoplasmacytic lymphoma of the larynx mimicking extramedullary plasmacytoma: A case report. Oncol Lett. 2024 Jan 30;27(3):132. doi: 10.3892/ol.2024.14265. eCollection 2024 Mar. PMID: 38362232
Tokuchi K, Yanagi T, Inamura E, Kawamura T, Seo T, Fujita Y, Nakagawa M, Kasahara I, Matsuno Y, Ujiie H. Morphea-like subcutaneous panniculitis-like T-cell lymphoma. JAAD Case Rep. 2024 Feb 10;46:27-29. doi: 10.1016/j.jdcr.2023.12.025. eCollection 2024 Apr. PMID: 38510836
〈招待口演〉Alloreactive T-cell targets tissue stem cells and impairs tissue homeostasis in GVHD after allogeneic stem cell transplantation. Takanori Teshima The 21th IRCMS Symposium on the Dynamics and Development of Normal and Malignant Hematopoietic Stem Cells Kumamoto,JAPAN 2024年2月
〈招待口演〉Optimal GVHD prophylaxis for cord blood transplant- The Japanese perspective. Takanori Teshima The 2nd Annual Stem Cell Transplant & Cell Therapy Symposium Phenix, USA 2024年3月
〈招待口演〉Modulation of T-cell functions to facilitate GVL after allogeneic hematopoietic stem cell transplantation. Takanori Teshima American Association for Cancer Research (AACR) Annual Meeting San Diego, USA 2024年4月
〈招待口演〉CAR-T cell therapy in Japan Takanori Teshima Taiwan Society of Blood and marrow Transplantation (TBMT) annual meeting 2024 2024年7月 Taipei, Taiwan
〈招待口演〉PTCy in unrelated and related peripheral blood stem cell transplantation from HLA matched and 1-2 allele mismatched donor Takanori Teshima The 8th International Congress of BMT 2024, The 29th Annual Congress of Korean Society of Blood and Marrow Transplantation Busan, Korea 2024年9月
〈招待口演〉Is post-transplant cyclophosphamide (PTCy) or anti-thymoglobulin (ATG) the current standard for GVHD prophylaxis in matched unrelated transplant? Takanori Teshima The 9th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) Berlin, Germany 2024年10月
〈招待口演〉Firing up cold tumor microenvironment to facilitate GVL Takanori Teshima American Society of Hematology Annual Meeting San Diego, USA 2024年12月
〈一般口演〉Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 Elara 3-Year Follow-up Schuster SJ, Fowler N, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell LL, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Perez-Simon JA, Chen A, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten P, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Zia A, Awasthi R, Paule I, Germano D, Ramos RJ, Hsu P, Thieblemont C, Dreyling M ASTCT2024 Annual Meeting San Antonio, USA 2024年2月
〈一般口演〉Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 Elara 3-Year Follow-up Schuster SJ, Fowler N, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell LL, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Perez-Simon JA, Chen A, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten P, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Zia A, Awasthi R, Paule I, Germano D, Ramos RJ, Hsu P, Thieblemont C, Dreyling M EBMT-EHA 6th European CAR T-cell Meeting Valencia,Spain 2024年2月
〈ポスター〉Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 Elara 3-Year Follow-up Schuster SJ, Fowler N, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell LL, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Perez-Simon JA, Chen A, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten P, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Zia A, Awasthi R, Paule I, Germano D, Ramos RJ, Hsu P, Thieblemont C, Dreyling M 29th European Hematology Association Congress Madrid,Spain 2024年6月
〈一般口演〉PHASE 3 JAPANESE STUDY OF BELUMOSUDIL, A SELECTIVE ROCK2 INHIBITOR, AS SECOND OR SUBSEQUENT LOT FOR STEROID-DEPENDENT/RESISTANT CHRONIC GVHD: ANALYSIS AT 48 WEEKS AFTER THE LAST PATIENT ENROLMENT Onishi Y, Inamoto Y, Kato K, Kawakita T, Matsuoka K, Shiratori S, Ikegame K, Hiramoto N, Toyosaki M, Katayama Y, Murayama S, Sasagawa Y, Teshima T, Hatake K, Maeda Y 29th European Hematology Association Congress Madrid,Spain 2024年6月
〈一般口演〉Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC Akahoshi Y, Inamoto Y, Spyrou N, Nakasone H, Ayuk FA, Choe H, Doki N, Eto T, Etra A, Hexner EO, Hiramoto N, Hogan WJ, Holler E, Kataoka K, Tanaka M, Tanaka T, Uchida N, Vasova I, Ishimaru F, Fukuda T, Chen Y-B, Kanda J, Nakamura R, Atsuta Y, Ferrara JLM, Kanda Y, Levine J, Teshima T American Society of Hematology Annual Meeting San Diego, USA 2024年12月
〈一般口演〉Clinical Outcomes of Patients with High-Risk Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 ELARA 4-Year Update Thieblemont C, Dreyling M, Dickinson MJ, Martínez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell LL, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen A, Nastoupil L, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Offner F, Viardot A, Zinzani PL, Malladi R, Zia A, Awasthi R, Germano D, Ramos RJ, Hsu P, Schuster SJ, Fowler NH American Society of Hematology Annual Meeting San Diego, USA 2024年12月
〈ポスター〉LETERMOVIR IS EFFECTIVE IN PREVENTING CYTOMEGALOVIRUS REACTIVATION AND IS ASSOCIATED WITH BETTER TRANSPLANT OUTCOME IN CORD BLOOD TRANSPLANTATION Takahide Ara, Y. Hasegawa, H. Ohigashi, T. Matsukawa, S. Shiratori, A. Yasumoto, H. Goto, M. Onozawa, M. Nakagawa, K. Kahata, T. Endo, D. Hashimoto, and T. Teshima EHA2024 Madrid 2024年6月
〈一般口演〉GVHD-Induced Inflammatory Memory in Intestinal Stem Cells Enhances IFN-y-Induced Antigen Presentation and Apoptosis of Intestinal Epithelial Cells Toru Miyajima, Daigo Hashimoto, Keisuke Kojima, Shihori Tsukamoto, Tomoe Ichiki, Yumika Saito, Wenyu Li, Zixuan Zhang, Shinpei Harada, Hajime Senjo, Yuki Yokoi, Yuta Hasegawa, Hiroyuki Ohigashi, Takahide Ara, Kiminori Nakamura, Koji Taniguchi and Takanori Teshima The 66th ASH Annual Meeting and Exposition San Diego, US 2024年12月
〈ポスター〉HokUS-10 scoring system predicts the treatment outcome for sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation Souichi Shiratori, Kohei Okada, Junichi Sugita, Mutsumi Nishida, Takahito Iwai, Shuichi Ota, Daigo Hashimoto, Takanori Teshima 024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR San Antonio 2024年2月
〈シンポジウム〉Recent progress of GVHD prophylaxis using ATG or PYCy Souichi Shiratori APBMT2024 Singapore（WEB） 2024年9月
〈ポスター〉Intact Mitochondrial Transfer Enhances Anti-tumor Effects of CAR-T Cells Shinpei Harada, Daigo Hashimoto, Toru Miyajima, Yumika Saito, Tomoe Ichiki, Hajime Senjo, Wenyu Li, Zixuan Zhang, Ryo Kikuchi, Masahiro Chiba, Masashi Suganuma2), Rick C. Tsai2) , Hiroyuki Ohigashi, Takahide Ara, Masao Nakagawa, Takanori Teshima the 14th JSH International Symposium 2024 Hakodate 2024年7月
〈ポスター〉Ptpn1 deficiency collaborates with a NUP98::HOXD13 fusion gene to generate B cell precursor acute lymphoblastic leukemia Nupur Nigam, Toshihiro Matsukawa, Ryan Bertoli, Michel L. Tremblay, Mianmian Yin, Peter D. Aplan AACR Annual Meeting 2024 San Diego, USA 2024年4月
〈ポスター〉Combination of Low White Blood Cell Count and Impaired Renal Function Is a Risk Factor for Higher Concentrations of Venetoclax and Prolonged Neutropenia in AML Patients with Venetoclax Combined Regimen: Real World Experience in the Japanese Cohort Minoru Kanaya, Yuji Mukai, Mirei Kobayashi, Sayaka Kajikawa, Toma Suzuki, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Masanobu Morioka, Akio Mori, Toshihiro Matsukawa, Masahiro Onozawa, Goichi Yoshimoto, Mitsuru Moriyama, Sunggi Chi, Takanori Teshima, Yosuke Minami, Masato Honmma, and Takeshi Kondo 66th ASH Annual Meeting & Exposition San Diego, USA 2024年12月
〈ポスター〉Kinetics of Recipients with Thrombocytopenia and Its Impact on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study Naoki Kurita, Kazushi Maruo, Fumihiko Kimura, Yachiyo Kuwatsuka, Toshihiro Matsukawa, Takaaki Konuma, Shinichi Kobayashi, Mamiko Sakata-Yanagimoto, Noriko Doki, Masatsugu Tanaka, MD, Naoyuki Uchida, Tetsuya Nishida, Masashi Sawa, Yuta Hasegawa, Hirohisa Nakamae, Shuichi Ota, Makoto Onizuka, Takahiro Fukuda, Fumihiko Ishimaru, Ken Tabuchi, Yoshiko Atsuta, Junya Kanda, and Hideki Nakasone 66th ASH Annual Meeting & Exposition San Diego, USA 2024年12月
〈ポスター〉Real-world effectiveness in treatment-experienced (TE) people with HIV (PWH) switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) with distinct patterns of self-reported adherence. Boffito M, Brunetta J, Levy I, Yang CJ, Portilla J, Barra E, Vogelmann R, Endo T, Robineau O, Sarmati L, Thorpe D, Marongiu A, Cassidy T, Welzen B HIV drug therapy Glasgow Glasgow_England 2024年11月
〈一般口演〉Ropeginterferon Alfa-2b Induces Apoptosis and Differentiation of Leukemia Stem Cells and Separates GVL Effects from Gvhd after Allogeneic Hematopoietic Cell Transplantation Yumika Saito, Daigo Hashimoto, Keisuke Kojima, Shihori Tsukamoto, Tomoe Ichiki, Toru Miyajima, Wenyu Li, Shinpei Harada, Zixuan Zhang, Hajime Senjo, Yuta Hasegawa, Takahide Ara, Takanori Teshima 66th ASH Annual Meeting & Exposition San Diego, USA 2024年12月
〈一般口演〉Early Initiation of Calcineurin Inhibitor Induces CD8 + Transitory Exhausted-like and CD4 Cytotoxic T Cells, Maintaining Responsiveness to PD-1 Blockade and Contributing to the Development of Chronic Gvhd after Post-Transplant Cyclophosphamide Hajime Senjo, Daigo Hashimoto, Shihori Tsukamoto, Keisuke Kojima, Shimpei I Kubota, Ayumu Ito, Tomoe Ichiki, Satomi Okada, Yumika Saito, Toru Miyajima, Shinpei Harada, Wenyu Li, Zixuan Zhang, Yuta Hasegawa, Hiroyuki Ohigashi, Takahide Ara, Yoshinori Hasegawa, Yoshihiro Inamoto, Masaaki Murakami, Takahiro Fukuda, Takanori Teshima 66th ASH Annual Meeting & Exposition San Diego, USA 2024年12月
〈ポスター〉Yuta Ito, Joji Shimono, Keisuke Kawamoto, Kanako C. Hatanaka, Yasunori Kogure, Kota Mizuno, Junji Koya, Koichi Murakami, Takanori Teshima, Yutaka Hatanaka, Hiroaki Miyoshi, Yoshihiro Matsuno, Koichi Ohshima, Keisuke Kataoka, and Masao Nakagawa TP53 and CDKN2A Alterations Define a Poor Prognostic Subgroup in Patients with Nodal T-Follicular Helper Cell Lymphoma 第64回日本リンパ網内系学会学術集会・総会 第27回日本血液病理研究会 東京 2024年6月
〈ポスター〉豊嶋崇徳, 尾崎正彦, 濱田昌宏, 前川慎一郎, 中林祥子, 伊藤雄一郎 Analysis of a post-marketing all-case surveillance of pembrolizumab in Japanese patients with relapsed/refractory classical Hodgkin lymphoma 第64回日本リンパ網内系学会学術集会・総会 第27回日本血液病理研究会 東京 2024年6月
〈ポスター〉Yuta Hasegawa, Daigo Hashimoto, Zixuan Zhang, Hajime Senjo, Takahide Ara, Toru Miyajima, Yumikca Saito, Wenyu Li and Takanori Teshima GVHD targets organoid-forming bill duct stem cells via a TGF-β-dependent manner The 1st Annual Meeting of the Japanese Cytokine Society (JCS2024) 札幌 2024年7月
〈一般口演〉Kikushige Y, Nakamae H, Goto T, Tomita A, Ichii M, Itou S, Teshima T, Kirito K, Ikezoe T, Hatano K, Tanaka H, Hiramoto N, Ueda Y, Osako R, Aoki M, Malek K, Takahashi N Asciminib in Japanese patients with newly diagnosed CML: ASC4FIRST Phase 3 study subgroup analysis 第86回日本血液学会学術集会 京都 2024年10月
〈一般口演〉Akahoshi Y, Inamoto Y, Uchida N, Doki N, Tanaka T, Kataoka K, Hiramoto N, Eto T, Tanaka MIshimaru F, Fukuda T, Kanda Y, Atsuta Y, Nakasone H, Kanda J, Ferrara JLM, Levine JE, Teshima T Refinement of Day 28 Overall Response for GVHD: International Collaboration Study of JSTCT anMAGIC 第86回日本血液学会学術集会 京都 2024年10月
〈一般口演〉Kumode T, Goto H, Mishima Y, Kataoka K, Ogawa Y, Kanemura N, Shimada K, Uchida T, Kuroe Y, Kawasaki A, Sato J, Teshima T Efficacy and safety of mosunetuzumab monotherapy in Japanese patients with R/R FL, FLMOON-1 trial 第86回日本血液学会学術集会 京都 2024年10月
〈一般口演〉Nakamura N, Morishita T, Kanemura N, Hayashi H, Okabe M, Nakasone H, Uchida N, Doki N, Fukuda T, Yoshihara S, Tanaka M, Nishida T, Hasegawa Y, Matsuoka K, Sawa M, Kato K, Ishimaru F, Tabuchi K, Atsuta Y, Teshima T The impact of the COVID-19 pandemic on CBT in Japan - Interrupted time series analysis - 第86回日本血液学会学術集会 京都 2024年10月
〈特別口演〉後藤秀樹 3L+DLBCLに対する治療選択 ～CAR-T vs Epcoritamab～ 第86回日本血液学会学術集会 京都 2024年10月
〈一般口演〉Hideki Goto, Franck Morschhauser, Loretta J. Nastoupil, Saurabh Dahiya, M. Lia PalombaAlejandro Martin, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jager, Guillaume Cartron, MartiDreyling, Brad Kahl, Herve Ghesquieres, Kirit Ardeshna, Anna Maria Barbui, Jeremy S. AbramsonPeter Borchmann, Isabelle Fleury, Stephan Mielke, Alan Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Rashmi Bhatnagar, Rina Nishii, Ariel Avilion, Jessica PapugaKoji Izutsu TRANSCEND FL: phase 2 study of lisocabtagene maraleucel (liso-cel) in R/R follicular lymphoma (FL)第86回日本血液学会学術集会 京都 2024年10月
